BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 25641599)

  • 1. Intraspinal administration of human spinal cord-derived neural progenitor cells in the G93A-SOD1 mouse model of ALS delays symptom progression, prolongs survival and increases expression of endogenous neurotrophic factors.
    Knippenberg S; Rath KJ; Böselt S; Thau-Habermann N; Schwarz SC; Dengler R; Wegner F; Petri S
    J Tissue Eng Regen Med; 2017 Mar; 11(3):751-764. PubMed ID: 25641599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the therapeutic potential of different administration routes and frequencies of human mesenchymal stromal cells in the SOD1
    Bursch F; Rath KJ; Sarikidi A; Böselt S; Kefalakes E; Osmanovic A; Thau-Habermann N; Klöß S; Köhl U; Petri S
    J Tissue Eng Regen Med; 2019 Apr; 13(4):649-663. PubMed ID: 30811816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial in vivo imaging of transplanted allogeneic neural stem cell survival in a mouse model of amyotrophic lateral sclerosis.
    Srivastava AK; Gross SK; Almad AA; Bulte CA; Maragakis NJ; Bulte JWM
    Exp Neurol; 2017 Mar; 289():96-102. PubMed ID: 28038988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS.
    Suzuki M; McHugh J; Tork C; Shelley B; Klein SM; Aebischer P; Svendsen CN
    PLoS One; 2007 Aug; 2(8):e689. PubMed ID: 17668067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
    Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GDNF delivery using human neural progenitor cells in a rat model of ALS.
    Klein SM; Behrstock S; McHugh J; Hoffmann K; Wallace K; Suzuki M; Aebischer P; Svendsen CN
    Hum Gene Ther; 2005 Apr; 16(4):509-21. PubMed ID: 15871682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagy activation and neuroprotection by progesterone in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis.
    Kim J; Kim TY; Cho KS; Kim HN; Koh JY
    Neurobiol Dis; 2013 Nov; 59():80-5. PubMed ID: 23891729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic treatment with adipose-derived mesenchymal stem cells ameliorates clinical and pathological features in the amyotrophic lateral sclerosis murine model.
    Marconi S; Bonaconsa M; Scambi I; Squintani GM; Rui W; Turano E; Ungaro D; D'Agostino S; Barbieri F; Angiari S; Farinazzo A; Constantin G; Del Carro U; Bonetti B; Mariotti R
    Neuroscience; 2013 Sep; 248():333-43. PubMed ID: 23727509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GLT1 overexpression in SOD1(G93A) mouse cervical spinal cord does not preserve diaphragm function or extend disease.
    Li K; Hala TJ; Seetharam S; Poulsen DJ; Wright MC; Lepore AC
    Neurobiol Dis; 2015 Jun; 78():12-23. PubMed ID: 25818008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth factor-expressing human neural progenitor cell grafts protect motor neurons but do not ameliorate motor performance and survival in ALS mice.
    Park S; Kim HT; Yun S; Kim IS; Lee J; Lee IS; Park KI
    Exp Mol Med; 2009 Jul; 41(7):487-500. PubMed ID: 19322031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS.
    Li W; Brakefield D; Pan Y; Hunter D; Myckatyn TM; Parsadanian A
    Exp Neurol; 2007 Feb; 203(2):457-71. PubMed ID: 17034790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
    Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
    Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplantation of clinical-grade human neural stem cells reduces neuroinflammation, prolongs survival and delays disease progression in the SOD1 rats.
    Zalfa C; Rota Nodari L; Vacchi E; Gelati M; Profico D; Boido M; Binda E; De Filippis L; Copetti M; Garlatti V; Daniele P; Rosati J; De Luca A; Pinos F; Cajola L; Visioli A; Mazzini L; Vercelli A; Svelto M; Vescovi AL; Ferrari D
    Cell Death Dis; 2019 Apr; 10(5):345. PubMed ID: 31024007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraspinal injection of human umbilical cord blood-derived cells is neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis.
    Knippenberg S; Thau N; Schwabe K; Dengler R; Schambach A; Hass R; Petri S
    Neurodegener Dis; 2012; 9(3):107-20. PubMed ID: 22122965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human neural stem cell replacement therapy for amyotrophic lateral sclerosis by spinal transplantation.
    Hefferan MP; Galik J; Kakinohana O; Sekerkova G; Santucci C; Marsala S; Navarro R; Hruska-Plochan M; Johe K; Feldman E; Cleveland DW; Marsala M
    PLoS One; 2012; 7(8):e42614. PubMed ID: 22916141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-dependent efficacy of ALS-human mesenchymal stem cells transplantation into cisterna magna in SOD1-G93A ALS mice.
    Kim H; Kim HY; Choi MR; Hwang S; Nam KH; Kim HC; Han JS; Kim KS; Yoon HS; Kim SH
    Neurosci Lett; 2010 Jan; 468(3):190-4. PubMed ID: 19879334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human mesenchymal stromal cells ameliorate the phenotype of SOD1-G93A ALS mice.
    Zhao CP; Zhang C; Zhou SN; Xie YM; Wang YH; Huang H; Shang YC; Li WY; Zhou C; Yu MJ; Feng SW
    Cytotherapy; 2007; 9(5):414-26. PubMed ID: 17786603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-kit is important for SOD1(G93A) mouse survival independent of mast cells.
    Staats KA; Schönefeldt S; Van Helleputte L; Van Rillaer M; Lampi Y; Dooley J; Van Den Bosch L; Liston A
    Neuroscience; 2015 Aug; 301():415-20. PubMed ID: 26112382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis.
    Wang LJ; Lu YY; Muramatsu S; Ikeguchi K; Fujimoto K; Okada T; Mizukami H; Matsushita T; Hanazono Y; Kume A; Nagatsu T; Ozawa K; Nakano I
    J Neurosci; 2002 Aug; 22(16):6920-8. PubMed ID: 12177190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human glial-restricted progenitor transplantation into cervical spinal cord of the SOD1 mouse model of ALS.
    Lepore AC; O'Donnell J; Kim AS; Williams T; Tuteja A; Rao MS; Kelley LL; Campanelli JT; Maragakis NJ
    PLoS One; 2011; 6(10):e25968. PubMed ID: 21998733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.